Ayala Pharmaceuticals Inc (ADXS)

[cab033]

Gold it is funny you mention LJPC because I saw that also and looked into them a bit this morning.

They are up big because they released great data on their P3 trials which has an SPA from the FDA. Prior to these results they were valued at roughly $360MM MC (look familiar?) They have around 86% institutional ownership at YE and just 9% of their float short. They have traded 16MM shares today as of now with only 18.3MM outstanding. The great P3 results coupled with the share info is what is driving the price today. Compare this to ADXS and things become more clear IMO. We have less ownership, more shorts, more available shares, and we are not releasing P3 results anytime soon.

Before we release P3 results I believe ownership will go up to 85-90% and shorts will be mostly gone. Then yes we could see a 50-100% increase day. But when are the 3P results expected?

I was surprised to see LJPC conducting a P3 SPA trial valued at the same market cap as us yet we are so "undervalued". I know there are some differences here but there are a lot of similarities also. I was also surprised to see a new bio company in a P3 with just 18MM shares outstanding. That is impressive.